AMN Healthcare Reports Strong Q3 2026 Results Driven by Nurse and Allied Solutions Growth
AMN Healthcare (AMN) reported robust third-quarter 2026 financial results, highlighted by a 13% year-over-year revenue increase to $717.3 million. The company saw significant growth in its Nurse and Allied Solutions segment, which rose 27% year-over-year, fueled by a 21% surge in travel nurse volume. Adjusted diluted EPS climbed significantly to $1.16 from $0.39 in the prior year period. The results were bolstered by a $51 million favorable adjustment related to labor disruption reserves, which improved consolidated gross margins to 31.9%. Despite these gains, management noted potential headwinds, including embassy visa appointment delays affecting international nurse growth and pricing pressures as clinicians seek higher rates. Fourth-quarter revenue guidance is set between $655 million and $670 million.
Tickers: $AMN
Topics: EBITDA EPS beat healthcare staffing labor disruption revenue growth